Jeff Yass’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,300
Closed -$29.8K 13404
2023
Q1
$29.8K Buy
+12,300
New +$34.1K ﹤0.01% 11915
2021
Q3
Sell
-8,000
Closed -$247K 13765
2021
Q2
$247K Sell
8,000
-3,600
-31% -$108K ﹤0.01% 11171
2021
Q1
$298K Buy
+11,600
New +$291K ﹤0.01% 10615

Other funds holding RNLX

Jeff Yass's RNLX Position: Q4 2023 in Review

Jeff Yass sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2023, closing a stake of 19,078 shares — an estimated $30.5K sold.

Jeff Yass first reported a position in RNLX in Q2 2021 and held it in 6 quarters. The position peaked at $807K in Q2 2021. 27 funds tracked by Wall St. Rank hold RNLX as of Q4 2023.

  • Jeff Yass reported no remaining Renalytix plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Jeff Yass sold 19,078 Renalytix plc American Depositary Shares shares in Q4 2023, an estimated $30.5K.
  • Jeff Yass first reported a position in Renalytix plc American Depositary Shares in Q2 2021 and held it in 6 quarters.
  • Jeff Yass's Renalytix plc American Depositary Shares position peaked at $807K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.